Literature DB >> 20042456

Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice.

Susan B Gurley1, Carrie L Mach, Johannes Stegbauer, Jihong Yang, Kamie P Snow, Ann Hu, Timothy W Meyer, Thomas M Coffman.   

Abstract

Previous studies have shown that Akita mice bearing the Ins2(+/C96Y) mutation have significant advantages as a type I diabetes platform for developing models of diabetic nephropathy (DN; Gurley SB, Clare SE, Snow KP, Hu A, Meyer TW, Coffman TM. Am J Physiol Renal Physiol 290: F214-F222, 2006). In view of the critical role for genetic factors in determining susceptibility to DN in humans, we investigated the role of genetic background on kidney injury in Akita mice. To generate a series of inbred Akita mouse lines, we back-crossed the Ins2(C96Y) mutation more than six generations onto the 129/SvEv and DBA/2 backgrounds and compared the extent of hyperglycemia and renal disease with the standard C57BL/6-Ins2(+/C96Y) line. Male mice from all three Akita strains developed marked and equivalent hyperglycemia. However, there were significant differences in the level of albuminuria among the lines with a hierarchy of DBA/2 > 129/SvEv > C57BL/6. Renal and glomerular hypertrophy was seen in all of the lines, but significant increases in mesangial matrix compared with baseline nondiabetic controls were observed only in the 129 and C57BL/6 backgrounds. In F1(DBA/2 x C57BL/6)-Ins2(+/C96Y) mice, the extent of albuminuria was similar to the parental DBA/2-Ins2(+/C96Y) line; they also developed marked hyperfiltration. These studies identify strong effects of genetic background to modify the renal phenotype associated with the Ins2(C96Y) mutation. Identification of these naturally occurring strain differences should prove useful for nephropathy modeling and may be exploited to allow identification of novel susceptibility alleles for albuminuria in diabetes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20042456      PMCID: PMC2838602          DOI: 10.1152/ajprenal.90515.2008

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  31 in total

1.  Impact of genetic background on nephropathy in diabetic mice.

Authors:  Susan B Gurley; Sharon E Clare; Kamie P Snow; Ann Hu; Timothy W Meyer; Thomas M Coffman
Journal:  Am J Physiol Renal Physiol       Date:  2005-08-23

2.  In mice, proteinuria and renal inflammatory responses to albumin overload are strain-dependent.

Authors:  David A Ishola; Dionne M van der Giezen; Brunhilde Hahnel; Roel Goldschmeding; Wilhelm Kriz; Hein A Koomans; Jaap A Joles
Journal:  Nephrol Dial Transplant       Date:  2005-12-02       Impact factor: 5.992

3.  Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guinea pig, ferret and mink.

Authors:  A Hem; A J Smith; P Solberg
Journal:  Lab Anim       Date:  1998-10       Impact factor: 2.471

4.  Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study.

Authors:  Johan Arnlöv; Jane C Evans; James B Meigs; Thomas J Wang; Caroline S Fox; Daniel Levy; Emelia J Benjamin; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Circulation       Date:  2005-08-08       Impact factor: 29.690

Review 5.  Microalbuminuria and potential confounders. A review and some observations on variability of urinary albumin excretion.

Authors:  C E Mogensen; E Vestbo; P L Poulsen; C Christiansen; E M Damsgaard; H Eiskjaer; A Frøland; K W Hansen; S Nielsen; M M Pedersen
Journal:  Diabetes Care       Date:  1995-04       Impact factor: 19.112

Review 6.  Genetic factors in the development of diabetic nephropathy.

Authors:  R Trevisan; G Viberti
Journal:  J Lab Clin Med       Date:  1995-10

7.  Low-grade albuminuria and the risks of hypertension and blood pressure progression.

Authors:  Thomas J Wang; Jane C Evans; James B Meigs; Nader Rifai; Caroline S Fox; Ralph B D'Agostino; Daniel Levy; Ramachandran S Vasan
Journal:  Circulation       Date:  2005-02-28       Impact factor: 29.690

8.  Characterization of susceptibility of inbred mouse strains to diabetic nephropathy.

Authors:  Zhonghua Qi; Hiroki Fujita; Jianping Jin; Linda S Davis; Yihan Wang; Agnes B Fogo; Matthew D Breyer
Journal:  Diabetes       Date:  2005-09       Impact factor: 9.461

Review 9.  Mouse models of diabetic nephropathy.

Authors:  Matthew D Breyer; Erwin Böttinger; Frank C Brosius; Thomas M Coffman; Raymond C Harris; Charles W Heilig; Kumar Sharma
Journal:  J Am Soc Nephrol       Date:  2004-11-24       Impact factor: 10.121

10.  A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse.

Authors:  J Wang; T Takeuchi; S Tanaka; S K Kubo; T Kayo; D Lu; K Takata; A Koizumi; T Izumi
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

View more
  60 in total

1.  The effects of Ins2(Akita) diabetes and chronic angiotensin II infusion on cystometric properties in mice.

Authors:  Paul C Dolber; Huixia Jin; Rashid Nassar; Thomas M Coffman; Susan B Gurley; Matthew O Fraser
Journal:  Neurourol Urodyn       Date:  2015-01       Impact factor: 2.696

2.  Implication of dysregulation of the canonical wingless-type MMTV integration site (WNT) pathway in diabetic nephropathy.

Authors:  T Zhou; X He; R Cheng; B Zhang; R R Zhang; Y Chen; Y Takahashi; A R Murray; K Lee; G Gao; J-X Ma
Journal:  Diabetologia       Date:  2011-10-21       Impact factor: 10.122

3.  Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy.

Authors:  Jan Wysocki; Minghao Ye; Ahmed M Khattab; Agnes Fogo; Aline Martin; Nicolae Valentin David; Yashpal Kanwar; Mark Osborn; Daniel Batlle
Journal:  Kidney Int       Date:  2016-12-04       Impact factor: 10.612

4.  Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy.

Authors:  Guangzhi Chen; Renfan Xu; Yinna Wang; Peihua Wang; Gang Zhao; Xizhen Xu; Artiom Gruzdev; Darryl C Zeldin; Dao Wen Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-06-26       Impact factor: 4.310

5.  Inflammation and Immunity Pathways Regulate Genetic Susceptibility to Diabetic Nephropathy.

Authors:  Susan B Gurley; Sujoy Ghosh; Stacy A Johnson; Kengo Azushima; Rashidah Binte Sakban; Simi E George; Momoe Maeda; Timothy W Meyer; Thomas M Coffman
Journal:  Diabetes       Date:  2018-07-31       Impact factor: 9.461

6.  Thrombospondin 1 and Its Diverse Roles as a Regulator of Extracellular Matrix in Fibrotic Disease.

Authors:  Joanne E Murphy-Ullrich
Journal:  J Histochem Cytochem       Date:  2019-05-22       Impact factor: 2.479

7.  Endothelial cell-specific overexpression of endothelial nitric oxide synthase in Ins2Akita mice exacerbates diabetic nephropathy.

Authors:  Mohan Natarajan; Samy L Habib; Robert L Reddick; Caroline R Delma; Krishnan Manickam; Thomas J Prihoda; Sherry L Werner; Sumathy Mohan
Journal:  J Diabetes Complications       Date:  2018-10-13       Impact factor: 2.852

8.  Blockade of TSP1-dependent TGF-β activity reduces renal injury and proteinuria in a murine model of diabetic nephropathy.

Authors:  Ailing Lu; Mi Miao; Trenton R Schoeb; Anupam Agarwal; Joanne E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

9.  Cytochrome P450 epoxygenase CYP2J2 attenuates nephropathy in streptozotocin-induced diabetic mice.

Authors:  Guangzhi Chen; Peihua Wang; Gang Zhao; Gang Xu; Artiom Gruzdev; Darryl C Zeldin; Dao Wen Wang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-06-30       Impact factor: 3.072

10.  Podocyte-specific knockout of cyclooxygenase 2 exacerbates diabetic kidney disease.

Authors:  Liming Wang; Yonggang Sha; Jingyi Bai; William Eisner; Matthew A Sparks; Anne F Buckley; Robert F Spurney
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.